Combination of low-dose cytarabine and 13-cis retinoic acid in the treatment of myelodysplastic syndromes
- 1 January 1987
- journal article
- clinical trial
- Published by Elsevier in Leukemia Research
- Vol. 11 (11) , 1041-1044
- https://doi.org/10.1016/0145-2126(87)90124-x
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Treatment of patients with myelodysplastic syndromes: A reviewScandinavian Journal of Haematology, 1986
- Treatment of acute myeloid leukemia developing after a myelodysplastic phase with low dose arabinosyl cytosineLeukemia Research, 1985
- Synergistic interaction between differentiation inducers and DNA synthesis inhibitors: A new approach to differentiation induction in myelodysplasia and acute myeloid leukaemiaLeukemia Research, 1985
- The effect of low dose Ara‐C in acute non‐lymphoblastic leukaemias and atypical leukaemiaBritish Journal of Haematology, 1984
- CYTARABINE IN PRE-LEUKAEMIAThe Lancet, 1984
- Response of Preleukemic Syndromes to Continuous Infusion of Low-Dose CytarabineNew England Journal of Medicine, 1983
- Treatment of acute myelocytic leukemia with low-dose cytosine arabinoside: Results of a pilot study in four patientsLeukemia Research, 1983
- Low dose arabinosyl cytosine for treatment of myelodysplastic syndromes and subacute myeloid leukemiaLeukemia Research, 1983
- Proposals for the classification of the myelodysplastic syndromesBritish Journal of Haematology, 1982
- Small doses of ARA-C in the treatment of acute myeloid leukaemia: differentiation of myeloid leukaemia cells?British Journal of Haematology, 1982